(19)
(11) EP 4 739 341 A1

(12)

(43) Date of publication:
13.05.2026 Bulletin 2026/20

(21) Application number: 24740407.2

(22) Date of filing: 05.07.2024
(51) International Patent Classification (IPC): 
A61K 39/00(2006.01)
C12N 15/113(2010.01)
(52) Cooperative Patent Classification (CPC):
A61K 2239/48; C12N 15/1138; C12N 2310/20; A61K 40/15; A61K 40/4224; A61K 40/50; A61K 40/31
(86) International application number:
PCT/EP2024/069002
(87) International publication number:
WO 2025/008507 (09.01.2025 Gazette 2025/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 06.07.2023 EP 23183973

(71) Applicant: Universitätsklinikum Hamburg-Eppendorf
20246 Hamburg (DE)

(72) Inventors:
  • AYUK, Ayuketang Francis
    20246 Hamburg (DE)
  • FEHSE, Boris
    20246 Hamburg (DE)
  • HARFMANN, Maraike
    22307 Hamburg (DE)
  • GLOW, Dawid
    20246 Hamburg (DE)
  • SCHROEDER, Tanja
    20246 Hamburg (DE)

(74) Representative: Eisenführ Speiser 
Patentanwälte Rechtsanwälte PartGmbB Johannes-Brahms-Platz 1
20355 Hamburg
20355 Hamburg (DE)

   


(54) MODIFIED NK CELL EXPRESSING A CHIMERIC ANTIGEN RECEPTOR